SFRP4 and cancer: Serum SFRP4 levels were significantly lower in cancer groups compared to the control group (2.1 ± 0.3 and 2.2 ± 0.4 in OC and EC (respectively) vs 2.9 ± 0.5 in the control group, p = 0.05).